Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4382101 | 0.78 | — | — | |
| SCHEMBL4382099 | 0.78 | — | — | |
| SCHEMBL15992870 | 0.76 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL15992872 | 0.76 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL28481611 | 0.73 | — | — | |
| Phosphine SCHEMBL10749768 | 0.73 | — | — | |
| SCHEMBL4437190 | 0.73 | ALDH1A1 (0.36) | ALDH1A1ALOX15 | |
| SCHEMBL28398749 | 0.64 | — | — | |
| SCHEMBL1767674 | 0.64 | — | — | |
| SCHEMBL2513584 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137623-A1 | STABLE CATALYST PRECURSOR OF RH COMPLEX CATALYSTS | EVONIK OXENO GMBH (DE) | 2010-06-03 | — | — | US | disclosed |
| EP-2147007-A1 | STABLE CATALYST PRECURSOR OF RH COMPLEX CATALYSTS | Evonik Oxeno GmbH (DE) | 2010-01-27 | — | — | EP | disclosed |
| WO-2008141853-A1 | STABLE CATALYST PRECURSOR OF RH COMPLEX CATALYSTS | EVONIK OXENO GMBH (DE) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137623-A1 | STABLE CATALYST PRECURSOR OF RH COMPLEX CATALYSTS | RFC2, RFC4, RFC5 | ALDH1A1 3659/4885ALOX15 3053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.